EP3222724

SILENCE THERAPEUTICS
Application Number
EP17160954A
Filing Date
Aug 5, 2003
Status
Granted And Under Opposition
Sep 28, 2018
Grant Date
Oct 31, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3222724B1 was granted to Silence Therapeutics on Oct 31, 2018 following the initial filing on Aug 5, 2003 under the application number EP17160954A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALNYLAM PHARMACEUTICALSOct 31, 2018WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents